Education
About Us
Working with TipRanks
Follow Us
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 45.15M | $ 29.43M | $ 18.51M | $ 12.40M | $ 8.40M |
| Gross Profit | $ 38.19M | $ 25.33M | $ 15.91M | $ 10.14M | $ 7.21M |
| Operating Income | $ -26.95M | $ -36.16M | $ -54.48M | $ -36.44M | $ -24.03M |
| EBITDA | $ -26.95M | $ -36.16M | $ -58.65M | $ -46.76M | $ -23.57M |
| Net Income | $ -39.23M | $ -33.23M | $ -59.36M | $ -47.19M | $ -28.84M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.44M | $ 8.53M | $ 11.78M | $ 9.41M | $ 30.30M |
| Total Assets | $ 35.33M | $ 23.97M | $ 24.60M | $ 22.00M | $ 37.84M |
| Total Debt | $ 34.44M | $ 23.63M | $ 1.59M | $ 1.96M | $ 0.00 |
| Net Debt | $ 14.00M | $ 15.10M | $ -10.18M | $ -7.45M | $ -30.30M |
| Total Liabilities | $ 69.19M | $ 49.87M | $ 51.66M | $ 34.32M | $ 6.93M |
| Stockholders' Equity | $ -33.86M | $ -25.89M | $ -27.07M | $ -12.32M | $ 30.90M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.93M | $ -41.19M | $ -51.17M | $ -33.10M | $ -23.95M |
| Operating Cash Flow | $ -18.01M | $ -40.84M | $ -50.58M | $ -32.31M | $ -22.70M |
| Investing Cash Flow | $ -838.00K | $ -345.00K | $ -1.59M | $ -1.79M | $ -2.26M |
| Financing Cash Flow | $ 30.76M | $ 37.94M | $ 54.63M | $ 13.46M | $ 50.77M |